Moderna (MRNA) Selling, General & Administrative (2018 - 2026)

Moderna (MRNA) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Moderna 22.52 Bn 17.32 Bn -566.00 Mn 173.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 173.00 Mn
Dec 31, 2025 308.00 Mn
Sep 30, 2025 268.00 Mn
Jun 30, 2025 230.00 Mn
Mar 31, 2025 212.00 Mn
Dec 31, 2024 351.00 Mn
Sep 30, 2024 281.00 Mn
Jun 30, 2024 268.00 Mn
Mar 31, 2024 274.00 Mn
Dec 31, 2023 470.00 Mn
Sep 30, 2023 442.00 Mn
Jun 30, 2023 332.00 Mn
Mar 31, 2023 305.00 Mn
Dec 31, 2022 375.00 Mn
Sep 30, 2022 278.00 Mn
Jun 30, 2022 211.00 Mn
Mar 31, 2022 268.00 Mn
Dec 31, 2021 201.00 Mn
Sep 30, 2021 168.00 Mn
Jun 30, 2021 121.00 Mn